DrugPatentWatch Database Preview
HALOTEX Drug Profile
see a sample report or, see our see our flat-rate plans
Which patents cover Halotex, and what generic alternatives are available?
The generic ingredient in HALOTEX is haloprogin. There is one drug master file entry for this compound. Additional details are available on the haloprogin profile page.
Summary for HALOTEX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 2 |
| Bulk Api Vendors: | 21 |
| Patent Applications: | 1,614 |
| DailyMed Link: | HALOTEX at DailyMed |
Synonyms for HALOTEX
| (3-Iod-2-propinyl)-(2,4,5-trichlorphenyl)ether |
| 1,2,4-Trichloro-5-(3-iodo-prop-2-ynyloxy)-benzene |
| 1,2,4-trichloro-5-(3-iodoprop-2-ynoxy)benzene |
| 1,2,4-trichloro-5-(3-iodoprop-2-ynyloxy)benzene |
| 1,2,4-trichloro-5-[(3-iodo-2-propynyl) oxy]benzene |
| 1,2,4-trichloro-5-[(3-iodoprop-2-yn-1-yl)oxy]benzene |
| 2,4,5-Trichlorophenyl .gamma.-iodopropargil ether |
| 2,4,5-Trichlorophenyl .gamma.-iodopropargyl ether |
| 2,4,5-Trichlorophenyl gamma-iodopropargil ether |
| 2,4,5-Trichlorophenyl iodopropargyl ether |
| 2,4,5-Trichlorophenyl-gamma-iodopropargyl ether |
| 2,5-Trichlorophenyl .gamma.-iodopropargil ether |
| 2,5-Trichlorophenyl .gamma.-iodopropargyl ether |
| 2,5-Trichlorophenyl iodopropargyl ether |
| 3-Iodo-2-propynyl 2,4,5-trichlorophenyl ether |
| 3-Iodo-2-propynyl 2,5-trichlorophenyl ether |
| 777-11-7 |
| 777H117 |
| AC1L1G7Q |
| AC1Q3I91 |
| AIU7053OWL |
| AKOS030627167 |
| aloprogen |
| AN-47592 |
| API0008981 |
| BDBM50194601 |
| Benzene, 1,2,4-trichloro-5-((3-iodo-2-propynyl)oxy)- |
| Benzene, 1,2,4-trichloro-5-[(3-iodo-2-propynyl)oxy]- |
| Benzene,1,2,4-trichloro-5-[(3-iodo-2-propynyl)oxy] |
| Benzene,2,4-trichloro-5-[(3-iodo-2-propynyl)oxy]- |
| BRD-K13238168-001-01-2 |
| BRN 1976771 |
| C9H4Cl3IO |
| CAS-777-11-7 |
| CCG-220402 |
| CHEBI:5614 |
| CHEBI:94512 |
| CHEMBL1289 |
| component of Halotex |
| CTETYYAZBPJBHE-UHFFFAOYSA-N |
| D00339 |
| D06ZAY |
| DB00793 |
| DivK1c_000762 |
| DSSTox_CID_26865 |
| DSSTox_GSID_46865 |
| DSSTox_RID_81972 |
| DTXSID9046865 |
| EINECS 212-286-6 |
| Ether, 3-iodo-2-propynyl 2,4,5-trichlorophenyl |
| Ether,4,5-trichlorophenyl |
| FCH1325214 |
| Haloprogen |
| haloprogin |
| Haloprogin (JAN/USAN/INN) |
| Haloprogin [USAN:INN:JAN] |
| Haloprogina |
| Haloprogina [INN-Spanish] |
| Haloprogine |
| Haloprogine [INN-French] |
| Haloproginum |
| Haloproginum [INN-Latin] |
| Halotex (Salt/Mix) |
| Halotex (TN) |
| HMS502G04 |
| IDI1_000762 |
| KBio1_000762 |
| KBio2_002365 |
| KBio2_004933 |
| KBio2_007501 |
| KBioSS_002369 |
| LS-67855 |
| M 1028 |
| M-1028 (Meiji) |
| Mycanden |
| Mycanden (TN) |
| Mycilan |
| Mycilan (TN) |
| NCGC00181134-01 |
| NCGC00181134-02 |
| NINDS_000762 |
| NSC 100071 |
| NSC-100071 |
| NSC100071 |
| OR070134 |
| OR340497 |
| Polik |
| Polik (TN) |
| Prestwick_232 |
| SCHEMBL3649 |
| Spectrum_001852 |
| Tox21_112741 |
| UNII-AIU7053OWL |
| WLN: I1UU2OR BG DG EG |
| Z3201 |
| ZINC1530649 |
US Patents and Regulatory Information for HALOTEX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Westwood Squibb | HALOTEX | haloprogin | CREAM;TOPICAL | 016942-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Westwood Squibb | HALOTEX | haloprogin | SOLUTION;TOPICAL | 016943-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
